Condition

Oligoastrocytoma (2)

Oligodendroglioma (2)

Anaplastic Oligodendroglioma (1)

Astrocytoma (1)

Glioma (1)

Overall Status

Terminated (1)

Withdrawn (1)

Sign in for free

Phase

n/a (1)

phase 2 (1)

Sponsor

Keryx / AOI Pharmaceuticals, Inc. (1)

University of Southern California (1)

Collaborator

National Cancer Institute (NCI) (1)

NovoCure Ltd. (1)

Intervention

quality-of-life assessment (1)

temozolomide and o6-benzylguanine (1)

wear novottf-200a (1)

Study Documents

Intervention Type

device (1)

drug (1)

procedure (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

Oligoastrocytoma

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Anaplastic Oligodendroglioma, Oligoastrocytoma, Oligodendroglioma Trial in Los Angeles (Wear novoTTF-200A, Quality-of-Life

Withdrawn

Anaplastic Oligodendroglioma
+2 more

Wear novoTTF-200A
Quality-of-Life Assessment

Los Angeles, California

USC / Norris Comprehensive Cancer Center

Dec 8, 2020

Glioma, Astrocytoma, Oligodendroglioma Trial in United States (Temozolomide and O6-Benzylguanine)

Terminated

Glioma
+3 more

Temozolomide and O6-Benzylguanine

Los Angeles, California
+11 more

Feb 7, 2012